Cancer Research

Cancer is a term used to define a group of diseases in which abnormal cells divide without control, are able to invade neighboring tissues/organs and metastasize. Cancer has been characterized by six hallmarks; self sufficiency in proliferative growth signals, insensitivity to growth inhibitors, evasion of apoptosis, limitless replicative potential, ability to develop blood vessels (angiogenesis), and tissue invasion and metastasis.

Cancer Research Products Areas

Products for Cancer Research - Page 114

Cat.No. Product Name Information/Activity
BCC5825 Ac2-26 Ac2-26, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
BCC3945 BIO 1211 Selective α4β1 (VLA-4) inhibitor
BCC8002 BIO 5192 327613-57-0
BCC3942 Cilengitide Cilengitide, a cyclic RGD-containing peptide, is a potent and selective integrin inhibitor for αvβ3 and αvβ5 receptor, with IC50s of 4 and 79 nM, respectively.
BCC5988 Echistatin, α1 isoform 154303-05-6
BCC6998 GR 144053 trihydrochloride 1215333-48-4
BCC5938 KF 38789 257292-29-8
BCC6229 LDV FITC 1207610-07-8
BCC6332 Leukadherin 1 Leukadherin-1 is a specific agonist of complement receptor 3 (CR3) and the leukocyte surface αMβ2 integrin CD11b/CD18.
BCC6105 PM 102 1234564-95-4